Tag Archives: Trastuzumab

Pertuzumab Plus Herceptin Shows Promise in Early Breast Cancer

Posted on December 22, 2010 by wngai

Just after four cycles of neoadjuvant use, the combination of Roche’s pertuzumab, Herceptin (trastuzumab) and chemotherapy improved the rate of complete tumor disappearance by more than half compared to conventional therapy in patients with HER2-positive breast cancer. The results came … Continue reading →

Posted in Breast cancer, Cancer | Tagged Breast cancer, HER2-positive, Herceptin, neoadjuvant, NEOSPHERE, Pertuzumab, Trastuzumab, tumor disappearance | Comments Off

HER2-positive Breast Cancer with Brain Metastases? Use Lapitinibi (Tykerb) and Capecitibine (Xeloda) but NOT Trastuzumab (Herceptin)

Posted on September 27, 2010 by wngai

Human epidermal growth factor receptor 2-positive (HER2+) breast cancer (BC) is a disease that accounts for up to one third of all invasive breast tumors. The natural history of this disease, however, has been dramatically improved with the introduction of … Continue reading →

Posted in Breast cancer, Cancer | Tagged Brain metastases, Breast cancer, Capecitibine, Her2, Herceptin, Lapitinib, Metastatic breast cancer, Survival, Trastuzumab, Tykerb, Xeloda | Comments Off

A New Treatment Option for patients with Gastric Cancer

Posted on September 12, 2010 by wngai

Gastric cancer is the fourth most commonly diagnosed cancer and the second most common cause of cancer-related deaths worldwide. Previous study has found that patients with operable disease have a 5-year survival rate of 36%. In patients with advanced or … Continue reading →

Posted in Cancer, Gastric Cancer | Tagged 5-Fluorouracil, capecitabine, chemotherapy, Cisplatin, Gastric Cancer, Gastro-esophageal Junction Cancer, Herceptin, Survival, Trastuzumab, Xeloda | Comments Off